Takashi Kubota

Faculty of Pharmaceutical Sciences,Department of Pharmaceutical SciencesLecturer
Last Updated :2025/08/28

■Researcher basic information

Degree

  • Ph. D. (Pharmaceutical Sciences), Kyushu University, Mar. 2005

Field Of Study

  • Life sciences, Pharmacology
  • Life sciences, Pharmacology
  • Life sciences, Neuropathology
  • Life sciences, Biophysics

■Career

Career

  • Apr. 2024 - Present
    Teikyo Heisei University, Faculty of Pharmaceutical Sciences
  • Apr. 2020 - Mar. 2024
  • Apr. 2007 - Mar. 2020
  • Apr. 2005 - Mar. 2007
  • Apr. 2005 - Aug. 2006

Educational Background

  • Apr. 2002 - Mar. 2005
  • Apr. 2000 - Mar. 2002
  • Apr. 1996 - Mar. 2000, Hoshi University

Member History

  • May 2016 - May 2016
  • Sep. 2009 - Oct. 2009

■Research activity information

Paper

MISC

Books and other publications

  • 薬学物理化学 -生体、薬へつながる他分野との架け橋として-               
    Joint editor
    Sep. 2023
    9784910844190
  • 研究者が教える動物実験 第3巻「行動」               
    Joint work
    2015
  • 研究者が教える動物実験 第3巻「行動」               
    Joint work
    2015

Lectures, oral presentations, etc.

  • A Cuprizone-induced neuroinflammation;mouse model with;prepulse inhibition deficit exhibited a complementary;yrosine hydroxylase abundance ratio in;he prefrontal cortex;midbrain               
    02 Dec. 2022
  • Behavioral disorders and expression changes of the tyrosine hydroxylase in Cuprizone-induced neuroinflammation mouse model with schizophrenia-like symptoms               
    KYOKA TSUKUDA; TAKASHI KUBOTA; AOI CHIBA; TAKASHI TOMINAGA; YASUSHI KISHIMOTO; KENTARO NAKASHIMA
    Neuroscience 2002
  • シナプス形成抑制因子MDGA1/2の欠失は対蹠的な興奮/抑制バランス偏移と行動異常を引き起こすが、成年期の薬剤投与により回復できる               
    02 Jul. 2022
  • ジャワショウガ抽出物trans-bangleneのタウオパチーモデルマウスの記憶障害に対する効果               
    08 Mar. 2022
  • Acute neuroinflammation induced by short-term treatment with Cuprizone leads to behavioral disorders similar to schizophrenia               
    30 Aug. 2021
  • 抑制性シナプス抑制因子MDGA1のヘミ欠損は海馬 LTPの低下と学習・記憶異常を引き起こすが、サイクロセリンの急性投与により回復する               
    29 Jul. 2021
  • Cuprizone短期投与による脳内炎症モデルマウスは統合失調症様精神行動障害を示す               
    29 Jul. 2021
  • Cuprizone短期投与脳内炎症モデルマウスは統合失調症様精神行動障害を示す               
    22 May 2021
  • MDGA1ノックアウトマウスの社会性行動に対するD-サイクロセリンの効果               
    27 Mar. 2021
  • タウタンパク質発現期間依存的な記憶およびタウタンパク質代謝の障害               
    27 Mar. 2020
  • Preventive effects of dietary intake of green algae on cuprizone-induced neuroinflammation in mouse               
    03 Dec. 2019
  • 薬学部の研究生産性に関する調査研究               
    09 Nov. 2019
  • 「タラウミジン誘導体の短段階合成法とアルツハイマー病モデルマウスに対する認知機能改善活性               
    22 Mar. 2019
  • Age-dependent impairment of memory, neurofibrillary tangle formation and clearance in a mouse model of tauopathy               
    14 Mar. 2019
  • Traumatic brain injury accelerates amyloid-b deposition and impairs learning and memory in the triple-transgenic mouse model of Alzheimer               
    Yutaka Kirino; Hajime Shishido; Nobuyui Kawai; Yasunori Toyota; Takashi Tamiya; Takashi Kubota; Masaki Ueno; Yasushi Kishimoto
    Neuroscience 2017
  • アルツハイマー病モデルマウスのα7ニコチン性アセチルコリン受容体を介した学習改善作用におけるmicroRNA-134の効果               
    24 Mar. 2017
  • アルツハイマー病モデルマウスの物体認識記憶におけるmicroRNA-132の2相性の効果               
    26 Mar. 2016
  • α7 ニコチン性アセチルコリン受容体作動薬の作業記憶増強作用におけるマイクロRNA-134 の関与               
    26 Mar. 2015
  • All-trans レチノイン酸の短期的投与がアルツハイマー病モデルマウスの認知・行動 に及ぼす効果               
    26 Mar. 2015
  • アルツハイマー病モデルマウスの物体認識記憶におけるmicroRNA-132の役割               
    27 Mar. 2014
  • アルツハイマー病モデルマウスの認知機能に対する外傷性脳損傷の影響               
    27 Mar. 2014
  • Biphasic effect of microRNA-132 on object recognition memory in Alzheimer’s disease mouse models               
    19 Mar. 2014
  • 外傷性脳損傷に伴うアルツハイマー病誘発の分子機構の解明               
    11 Oct. 2013
  • 作業記憶おける細胞膜結合型エストロゲン受容体GPR30の関与               
    27 Mar. 2013
  • Involvement of membrane-associated estrogen receptor GPR30 in the object recognition memory in Alzheimer's disease mouse models               
    21 Mar. 2013
  • 作業記憶および物体認識記憶における細胞膜結合型エストロゲン受容体GPR30の関与               
    14 Mar. 2013
  • アルツハイマー病およびプリオン病モデルマウスを用いた瞬目反射条件付けの解析               
    14 Mar. 2013
  • アルツハイマー病モデルマウスの物体認知記憶における細胞膜貫通型エストロゲン受容体GPR30の役割               
    29 Mar. 2012
  • Involvement of microRNA-134 in the working memory-enhancing effect of nicotinic acetylcholine receptor agonist               
    14 Mar. 2012
  • Contribution of & alpha-7 nicotinic acetylcholine receptor to the classical eyeblink conditioning in Alzheimer’s disease model mice               
    20 Sep. 2010
  • 老化マウス及びアルツハイマー痴呆症マウスモデルにおける瞬目反射条件付けに対するニコチンの効果               
    28 Jul. 2010
  • 老化マウスおよびアルツハイマー病モデルマウスの瞬目反射条件付け学習におけるニコチン性アセチルコリン受容体の関与               
    16 Mar. 2010
  • Contribution of nicotinic acetylcholine receptor to the classical eyeblink conditioning in aged mice and Alzheimer’s disease model mice               
    30 Oct. 2009
  • Involvement of brain cannabinoid system to trace eyeblink classical conditioning in diet-induced obese mice               
    03 Dec. 2008
  • Involvement of arachidonic acid cascade in morphine dependence               
    21 Dec. 2007
  • 肥満モデルマウスの瞬目反射条件付け学習におけるカンナビノイドの関与               
    16 Jun. 2007
  • 肥満モデルマウスにおける瞬目反射条件付け学習に対するカンナビノイシステムの関与               
    28 Mar. 2007
  • Influence of cannabinoid system on the classical eyeblink conditioning in diet-induced obese mice               
    14 Mar. 2007
  • モルヒネ探索行動の再燃および身体依存形成におけるアラキドン酸カスケードの関与               
    06 Jul. 2005
  • モルヒネ探索行動の再燃および身体依存形成に対するアラキドン酸カスケードの関与               
    21 Mar. 2005
  • モルヒネ自己摂取行動の発現に、アラキドン酸カスケードが関与する               
    28 Nov. 2003
  • 薬物自己投与法を用いてのモルヒネ報酬効果発現におけるアラキドン酸カスケードの関与               
    08 Oct. 2003
  • Involvement of arachidonic acid cascade in suppression of lever pressing behavior by repeated treatment of Δ8-tetrahydrocannabinol               
    24 Mar. 2003
  • Repeated Δ8-tetrahyrocannabinol enhances cyclooxygenase protein expression in the rat brain               
    15 Mar. 2002
  • Δ8-テトラヒドロカンナビノールによるシクロオキシゲナーゼの発現変化               
    Aug. 2001

Research Themes

  • Learning and Memory Performance of Alzheimer Disease Mouse Model with Mutant Human Tau Protein
    Grant-in-Aid for Scientific Research (C)
    Tokushima Bunri University
    Apr. 2016 - Mar. 2020
    rTg4510 mice constitutively express mutant human tau protein until transgene expression is inactivated by administration of the doxycycline (DOX). In 6-month-old (young) rTg4510 mice, the hippocampus dependent learning abilities including spatial memory, object recognition memory, and trace eyeblink conditioning were impaired. These impairments were reduced by pre-treatment with DOX for 2 months. In parallel, the expression of NFTs decreased in DOX-treated group. 10-month-old (aged) rTg4510 mice showed severe recognition impairment and increased levels of NFTs. Treatment with DOX could not ameliorate the tau pathology in aged rTg4510 mice as well as DOX-untreated group. Since the amount of autophagy markers decreased along with the amelioration of tau pathology, clearance mechanisms of NFTs via autophagy have kept normal functions in 4- to 6-month-old mice while, in 10-month-old mice, clearance system may reach a saturation level.
  • An Attempt to Detect a Neural Activity Change during Eyeblink Conditioning in Monkeys with PET Imaging
    Grant-in-Aid for Scientific Research (C)
    Tokushima Bunri University
    Apr. 2012 - Mar. 2016
    We developed a system which enables us to measure eyeblink conditioning in a monkey species (Macaca mulatta) with a brain size suitable for PET imaging. Eyeblinking was monitored simultaneously by orbicularis oculi electromyographic measurements and a high-speed camera. This system based on the two different principles yielded an interesting finding that the probability of observing a conditioned response in a given trial was not influenced by whether the monkeys closed their eyelids just before conditioned stimulus, suggesting that this memory could be expressed independently of wakefulness.
    We tried to gain PET imaging using a selective agonist cannabinoid-1 receptor tracer [11C]CB-119. However, the attempt was not completed due to the limited availability of expensive animals and PET ligands. Nevertheless, this study presents a novel system for cognitive assessment in monkeys that will be useful for elucidating the neural mechanisms of implicit learning in nonhuman primates.
  • A study on molecular and neural mechanism of eyeblink conditioning
    Grant-in-Aid for Scientific Research (A)
    2005 - 2008

Others

  • 麻薬研究者免許
    Jan. 2021 - Present
  • 薬剤師免許
    Jun. 2000 - Present